📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (2014)

First Author: Giagounidis A

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cncr.28663

PubMed Identifier: 24706489

Publication URI: http://europepmc.org/abstract/MED/24706489

Type: Journal Article/Review

Volume: 120

Parent Publication: Cancer

Issue: 12

ISSN: 0008-543X